Exercise Rehabilitation for Children With Asthma
Personalized Exercise Rehabilitation for Pediatric and Adolescent Asthma: A Comprehensive Intervention Study
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
Asthma, a prevalent chronic condition among children and adolescents, substantially impairs their quality of life. In addressing this significant health concern, this study focuses on the potential of a customized exercise rehabilitation program tailored for this young demographic. By employing a randomized controlled trial design, the research aims to divide participants into two distinct groups: one undergoing a personalized exercise regimen and the other receiving standard medical care. The 12-week intervention for the exercise group includes a combination of aerobic activities, strength training, and targeted breathing exercises. The study's primary aim is to rigorously evaluate the impact of this specialized exercise protocol on critical health aspects such as lung function, physical endurance, frequency of asthma attacks, and overall quality of life. The anticipated findings from this research are expected to shed new light on effective asthma management strategies and offer invaluable guidance for clinical practices dedicated to improving health outcomes in young asthma patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 31, 2024
CompletedFirst Posted
Study publicly available on registry
February 22, 2024
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2027
February 22, 2024
February 1, 2024
3 years
January 31, 2024
February 14, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Lung Function
Forced Vital Capacity (FVC), Forced Expiratory Volume in One Second (FEV1), Forced Expiratory Flow 25% to 75% (FEF25-75), Peak Expiratory Flow (PEF)
up to 24 weeks
Daily Physical Activity Level
Daily Step Count (as measured by a pedometer), Energy Expenditure,Time Spent in Moderate-to-Vigorous Intensity Activity
up to 24 weeks
Secondary Outcomes (7)
Asthma Control Status
up to 24 weeks
Fractional Exhaled Nitric Oxide (FeNO)
up to 12 weeks
Body Composition
up to 24 weeks
Sleep
up to 24 weeks
Health Related Quality of Life
up to 24 weeks
- +2 more secondary outcomes
Study Arms (2)
No Intervention Control Group
NO INTERVENTIONThe control group will not receive any specific intervention, continuing with their usual asthma management routine.
Exercise Rehabilitation Group
EXPERIMENTALThe experimental group will participate in a 12-week exercise intervention program.
Interventions
The experimental group will participate in a 12-week exercise intervention program, carefully transitioning from moderate-intensity interval training to high-intensity interval training. The progression of exercise intensity will be regularly adjusted based on each child's tolerance, ensuring a personalized approach to the regimen. The exercise program is structured into three phases: an adaptation phase, an intensification phase, and a consolidation phase. For each participant, the intensity of the exercises is calculated based on their reserve heart rate, allowing for a tailored and scientifically-grounded progression. This approach aims to optimize the exercise program's effectiveness while maintaining safety and adaptability to individual fitness levels and asthma conditions.
Eligibility Criteria
You may qualify if:
- Diagnosed with bronchial asthma;
- No acute asthma attacks in the past three months;
- Currently undergoing stable prophylactic treatment for asthma, with no changes in the treatment plan in the past three months.
You may not qualify if:
- Suffering from other severe heart, lung, or musculoskeletal diseases;
- Frequent acute asthma attacks or recent hospitalization records;
- Changes in asthma medication treatment plan in the last three months;
- Currently participating in other clinical trials that could affect the results of this study;
- Any medical contraindications, such as severe exercise-induced asthma or other health issues affecting the ability to exercise;
- Severe psychological or behavioral issues that may affect participation in training or adherence to the research protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 31, 2024
First Posted
February 22, 2024
Study Start
April 1, 2024
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
October 1, 2027
Last Updated
February 22, 2024
Record last verified: 2024-02